1. Safety and efficacy of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: A systematic review and meta-analysis
   Jing Wu et al, 2023, Frontiers in Immunology CrossRef
2. Dosimetric comparison of free-breathing versus respiratory motion-managed radiotherapy via four-dimensional computed tomography-based volumetric-modulated arctherapy for lung cancer
   S. Sarihan et al, 2023, Cancer/Radiothérapie CrossRef
3. Pneumonitis Risk After Chemoradiotherapy With and Without Immunotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
   Chong Han et al, 2024, International Journal of Radiation Oncology*Biology*Physics CrossRef
4. Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial
   Tianxiang Cui et al, 2023, Radiotherapy and Oncology CrossRef
5. Size and Predictive Factors of Microscopic Tumor Extension in Locally Advanced Non-Small Cell Lung Cancer
   Claire Meynard et al, 2021, Practical Radiation Oncology CrossRef
6. The clinical target volume in lung, head-and-neck, and esophageal cancer: Lessons from pathological measurement and recurrence analysis
   Rudi Apolle et al, 2017, Clinical and Translational Radiation Oncology CrossRef
7. Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy
   Nikhil Yegya-Raman et al, 2019, Practical Radiation Oncology CrossRef
8. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis
   Tingting Liu et al, 2023, eClinicalMedicine CrossRef